A Multicenter, Randomized, Blinded, Placebo-controlled, Phase IIa Study of Human Monoclonal Antibody to IL-12p40 (CNTO 1275) in Subjects With Crohn's Disease Inadequately Controlled by 5-Aminosalicylates and/or Corticosteroids,

  • De Villiers, Willem (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date3/17/04 → 5/31/08